Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by Rude_Boy_Boyon Oct 29, 2010 3:08pm
448 Views
Post# 17632255

Link for short cover

Link for short coverA short cover seems to have caused the buying yesterday and today. This stock had been reportedly shorted millions of shares on the us side and due to stronger SEC laws they were forced to cover.

https://ca.hotstocked.com/article/3189/stem-cell-therapeutics-corp-cve-sss.html



All the rest of the buyers must have saw the smoke and thought there was a fire. It seems the shorts have the last laugh
Bullboard Posts